MCID: BLS007
MIFTS: 38

Blastic Plasmacytoid Dendritic Cell malady

Categories: Rare diseases, Cancer diseases, Blood diseases, Immune diseases

Aliases & Classifications for Blastic Plasmacytoid Dendritic Cell

About this section
Sources:
45NIH Rare Diseases, 51Orphanet, 65UMLS, 28ICD10 via Orphanet, 27ICD10
See all MalaCards sources

Aliases & Descriptions for Blastic Plasmacytoid Dendritic Cell:

Name: Blastic Plasmacytoid Dendritic Cell 45
Blastic Plasmacytoid Dendritic Cell Neoplasm 45 51 65
Lymphoblastoid Variant of Nk-Cell Lymphoma 45 51
Cd4+/cd56+ Hematodermic Neoplasm 45 51
 
Monomorphic Nk-Cell Lymphoma 45 51
Blastic Nk-Cell Lymphoma 45 51
Bpdcn 45 51

Classifications:



External Ids:

Orphanet51 86870
ICD10 via Orphanet28 C86.4
ICD1027 C86.4
UMLS65 C1301363

Summaries for Blastic Plasmacytoid Dendritic Cell

About this section
MalaCards based summary: Blastic Plasmacytoid Dendritic Cell, also known as blastic plasmacytoid dendritic cell neoplasm, is related to breast cancer and cushing's syndrome. An important gene associated with Blastic Plasmacytoid Dendritic Cell is NCAM1 (Neural Cell Adhesion Molecule 1), and among its related pathways are Cell adhesion molecules (CAMs) and Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers. Affiliated tissues include nk cells, myeloid and brain, and related mouse phenotypes are tumorigenesis and no phenotypic analysis.

Related Diseases for Blastic Plasmacytoid Dendritic Cell

About this section

Graphical network of the top 20 diseases related to Blastic Plasmacytoid Dendritic Cell:



Diseases related to blastic plasmacytoid dendritic cell

Symptoms for Blastic Plasmacytoid Dendritic Cell

About this section

Drugs & Therapeutics for Blastic Plasmacytoid Dendritic Cell

About this section

Drugs for Blastic Plasmacytoid Dendritic Cell (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 26)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
ado-trastuzumab emtansineapprovedPhase 2621018448-65-1
Synonyms:
Kadcyla
 
Trastuzumab-DM1
trastuzumab emtansine
trastuzumab-MCC-DM1
2
Trastuzumabapproved, investigationalPhase 2726180288-69-19903
Synonyms:
180288-69-1
Anti HER2
Anti-erbB2 Monoclonal Antibody
D03257
HER2 Monoclonal Antibody
Herceptin
 
Herceptin (TN)
Ig gamma-1 chain C region
Trastuzumab
Trastuzumab (INN)
Trastuzumab (genetical recombination)
Trastuzumab (genetical recombination) (JAN)
trastuzumab
3Antimitotic AgentsPhase 24296
4Antineoplastic Agents, PhytogenicPhase 24294
5Tubulin ModulatorsPhase 24279
6MaytansinePhase 251
7
Miconazoleapproved, investigational302622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
Desenex
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Makesense
Micantin (nitrate)
Micatin
 
Miconasil Nitrate
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Oravig
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
Rash Relief Antifungal
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
8
Fludarabineapproved105921679-14-1, 75607-67-930751
Synonyms:
(2R,3S,4S,5R)-2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
2-F-ara-A
2-Fluoro Ara-A
2-Fluoro-9-beta-D-arabinofuranosyladenine
2-Fluoro-ara AMP
2-Fluoroadenine arabinoside 5'-monophosphate
21679-14-1
2F-Ara-AMP
9-beta-Arabinofuranosyl-2-fluoroadenine-5'-phosphate
9-beta-D-Arabinofuranosyl-2-fluoroadenine
9-beta-D-Arabinofuranosyl-2-fluoroadenine 5'-(dihydrogen phosphate)
9-beta-D-Arabinofuranosyl-2-fluoroadenine 5'-monophosphate
9-beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine
9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro- (9CI)
AC1LCW8I
AC1Q51CF
C10H12FN5O4
CCRIS 3382
CHEMBL1568
CID657237
CPD000058874
D07966
EINECS 244-525-5
F-Ara-A
FAMP
FT-0082766
FaraA
Fludara
 
Fludara, Fludarabine
Fludarabina
Fludarabina [Spanish]
Fludarabine
Fludarabine (INN)
Fludarabine 5'-monophosphate
Fludarabine Phosphate
Fludarabine [INN]
Fludarabine monophosphate
Fludarabine phosphate
Fludarabinum
Fludarabinum [Latin]
Fludura
Fluradosa
Fluradosa (TN)
HSDB 6964
I14-4978
LS-15061
MLS000028687
NSC 118218
NSC 118218H
NSC-118218
Oforta
S1491_Selleck
SAM002548956
SMR000058874
SQ Fludarabine
UNII-1X9VK9O1SC
UNII-P2K93U8740
ZINC04216238
9
Mycophenolate mofetilapproved, investigational898128794-94-55281078
Synonyms:
115007-34-6
128794-94-5
140401-05-4
2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate
2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)
AC-1562
AC1NQXZW
AC1Q6O6X
AR-1J6939
BB_NC-2566
C07908
C23H31NO7
CHEMBL1456
CID5281078
CellCept
CellCept, RS 61443, TM-MMF, Mycophenolate mofetil
Cellcept
Cellcept (TN)
D00752
DB00688
HMS2090A03
 
HSDB 7436
I01-0898
I06-1947
LS-172272
LS-75572
ME-MPA
MMF
MMF CellCept(TM)
MolPort-000-883-800
Munoloc
Mycophenolate Mofetil
Mycophenolate mofetil (JAN/USAN)
Mycophenolic acid morpholinoethyl ester
Mycophenylate mofetil
NCGC00159459-02
NCGC00159459-03
NSC724229
R-99
RS 61443
RS-61443
RS-61443-190
S1501_Selleck
TL8000648
TM-MMF
UNII-9242ECW6R0
ZINC21297660
mycophenolate mofetil
10
Vidarabineapproved23824356-66-932326, 21704
Synonyms:
(+)-Cyclaradine
.beta.-Adenosine
.beta.-D-Adenosine
1odi
2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol
2946-52-3
2fqy
2gl0
30143-02-3
3080-29-3
3228-71-5
4005-33-8
46946-45-6
46969-16-8
524-69-6
5536-17-4
58-61-7
9-Arabinosyladenine
9-beta-D-Arabinofuranosyl-9H-purin-6-amine
9-beta-D-Arabinofuranosyl-adenine
9-beta-D-Arabinofuranosyladenine
9-beta-D-arabinofuranosyl-adenine
9-╬▓-D-arabinofuranosyl-9H-purin-6-amine
9-╬▓-D-arabinofuranosyladenine
A 9251
A0152
A4036_SIGMA
A4676_SIGMA
A5762_SIGMA
A9251_SIGMA
AC1L18OL
AC1L1U8O
AC1L2IWM
AC1L2SCM
AC1O4WIN
AC1O8PY7
AC1Q1ID3
AC1Q4Y1Z
AC1Q52XU
ADENOSINE, U.S.P.
ADN
AI3-52413
AI3-52821
AR-1H6029
ARA-A NSC 247519
Ade-Rib
Adenine Arabinoside
Adenine arabinoside
Adenine nucleoside
Adenine riboside
Adenine xyloside
Adenocard
Adenocard (TN)
Adenocard, Adenosine
Adenocor
Adenoscan
Adenoscan (TN)
Adenosin
Adenosin [German]
Adenosine (JAN/USP)
Adenosine [USAN:BAN]
Adenosine arabinose
Adenosine-8-14C
Adensoine
Ambap5536-17-4
Ara A
Ara-A
Ara-ATP
Araadenosine
Arabinoside Adenine
Arabinoside adenine
Arabinosyl Adenine
Arabinosyl adenine
Arabinosyl-adenine
Arabinosyladenine
Arasena-A
Armes
Armes (TN)
BB_NC-0565
BPBio1_000898
BRN 0624881
BSPBio_000816
BSPBio_001796
BSPBio_002000
Bio1_000437
Bio1_000926
Bio1_001415
Boniton
C00212
CAS-5536-17-4
CCRIS 2557
CCRIS 3383
CHEBI:136932
CHEBI:16335
CHEBI:45327
CHEMBL1090
CHEMBL20247
CHEMBL477
CI 673
CI-673
CID102198
CID191
CID21704
CID60961
CID6420052
CID6713976
CPD000471872
Caswell No. 010B
D000241
D00045
D06298
DB00640
DivK1c_000191
EINECS 200-389-9
EINECS 217-911-6
EINECS 226-893-9
EU-0100123
FT-0082881
HMS1570I18
HMS1920A13
HMS1921K05
HMS2090F06
HMS2091G13
HMS2092C16
HMS500J13
HSDB 6514
 
I01-1121
IDI1_000191
KBio1_000191
KBio2_002418
KBio2_004986
KBio2_007554
KBio3_001296
KBio3_001500
KBioGR_001224
KBioSS_002424
L000094
LS-15059
LS-15085
Lopac0_000123
MEDR-640
MLS000069638
MLS000699527
MLS001066352
MLS001333133
MLS001333134
MLS002153227
MLS002153992
MolPort-001-785-903
MolPort-001-838-229
MolPort-003-666-308
Myocol
NCGC00016656-01
NCGC00023673-03
NCGC00023673-04
NCGC00023673-05
NCGC00023673-06
NCGC00023673-07
NCGC00094579-01
NCGC00094579-02
NCGC00094579-03
NCGC00094579-04
NCGC00178869-01
NCGC00179417-01
NCI60_003823
NCI60_037192
NCIOpen2_003303
NCIOpen2_005376
NINDS_000191
NSC 247519
NSC 404241
NSC 627048
NSC 7359
NSC 7652
NSC-404241
NSC247519
NSC404241
NSC627048
NSC70422
NSC7359
NSC7652
NSC80832
NSC87676
NSC91041
Nucleocardyl
PDSP1_001036
PDSP2_001020
Pallacor
Polyadenosine
Polyriboadenosine
Prestwick0_000768
Prestwick1_000768
Prestwick2_000768
Prestwick3_000768
Prestwick_983
RAB
S1647_Selleck
S1784_Selleck
SAM002564191
SMP1_000312
SMR000058216
SMR000225041
SMR000471872
SMR001233326
SPBio_001194
SPBio_001491
SPBio_002755
SPECTRUM1500107
SPECTRUM1500609
SR 96225
SR-96225
STK361815
SUN-Y4001
Sandesin
Spectrum2_001257
Spectrum2_001336
Spectrum3_000288
Spectrum3_000580
Spectrum4_000782
Spectrum5_001429
Spectrum_001894
Spongoadenosine
TL8003749
UNII-3XQD2MEW34
UNII-K72T3FS567
USAF CB-10
V0098
VIRDARABINE
Vidarabin
Vidarabina
Vidarabina [DCIT]
Vidarabine
Vidarabine (JAN)
Vidarabine anhydrous
Vidarabinum
Vira ATM
Vira-A
Vira-A, Vidarabine
XA
Xylosyl A
Xylosyladenine
ZINC00970363
ZINC02169830
adenine-D-ribose
adenosine
alpha-Ara A
beta-Adenosine
beta-Ara A
beta-D-Adenosine
bmse000061
nchembio.143-comp9
nchembio.186-comp109
nchembio.64-comp4
nchembio706-5
11
Mycophenolic acidapproved89824280-93-1446541
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
Acide mycophenolique
Acido micofenolico
Acidum mycophenolicum
Melbex
 
Micofenolico acido
Mycophenoic acid
Mycophenolate
Mycophenolic Acid
Mycophenolsaeure
Myfortic
12Vidarabine Phosphate119
13Fludarabine phosphate105930751
14Dermatologic Agents4555
15Immunosuppressive Agents10422
16Immunologic Factors18483
17Antirheumatic Agents8496
18Antifungal Agents3015
19Antibiotics, Antitubercular5971
20Anti-Bacterial Agents9140
21Anti-Infective Agents17220
22Antimetabolites9454
23Calcineurin Inhibitors1223
24Antiviral Agents8071
25Antimetabolites, Antineoplastic5770
26Cyclosporins873

Interventional clinical trials:

idNameStatusNCT IDPhase
1DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromesCompletedNCT00397579Phase 1, Phase 2
2SL-401 in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid LeukemiaRecruitingNCT02113982Phase 1, Phase 2
3An Open-label Phase II Study of Lorvotuzumab MertansineRecruitingNCT02420873Phase 2
4MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaCompletedNCT01231919Phase 1
5PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic MalignanciesNot yet recruitingNCT02730312Phase 1
6Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin LymphomaRecruitingNCT02652715
7Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic MalignanciesActive, not recruitingNCT00014235

Search NIH Clinical Center for Blastic Plasmacytoid Dendritic Cell

Genetic Tests for Blastic Plasmacytoid Dendritic Cell

About this section

Anatomical Context for Blastic Plasmacytoid Dendritic Cell

About this section

MalaCards organs/tissues related to Blastic Plasmacytoid Dendritic Cell:

33
Nk cells, Myeloid, Brain, Heart, Prostate, Kidney, Breast

Animal Models for Blastic Plasmacytoid Dendritic Cell or affiliated genes

About this section

MGI Mouse Phenotypes related to Blastic Plasmacytoid Dendritic Cell:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020069.1CDKN1B, CDKN2A, MYD88, NPM1, TET2
2MP:00030128.4CD4, CDKN1B, CDKN2A, CLEC4C, MYD88, TET2
3MP:00053818.1CD4, CDKN1B, CDKN2A, MYD88, PECAM1, SPIB
4MP:00053847.2CD4, CDKN1B, CDKN2A, MYD88, NCAM1, NPM1
5MP:00053976.9CD4, CDKN1B, CDKN2A, IL3RA, MYD88, NPM1
6MP:00053876.6CD4, CDKN1B, CDKN2A, IL3RA, MYD88, NPM1

Publications for Blastic Plasmacytoid Dendritic Cell

About this section

Articles related to Blastic Plasmacytoid Dendritic Cell:

(show top 50)    (show all 146)
idTitleAuthorsYear
1
Histopathological, immunohistochemical, and image analytic parameters characterizing the stromal component in primary and recurrent giant cell tumor of bone. (27182148)
2016
2
Association between variants A69S in ARMS2 gene and response to treatment of exudative AMD: a meta-analysis. (25185256)
2015
3
Neonatal Herpes Simplex Virus Type 1 Infection and Jewish Ritual Circumcision With Oral Suction: A Systematic Review. (26407411)
2015
4
Fast and Painless Skin Tag Excision with Ethyl Chloride. (26044394)
2015
5
Gas6 enhances axonal ensheathment by MBP+ membranous processes in human DRG/OL promyelinating co-cultures. (24476104)
2014
6
The individual N- and C-lobes of calmodulin tether to the Cav1.2 channel and rescue the channel activity from run-down in ventricular myocytes of guinea-pig heart. (25268113)
2014
7
Temporomandibular disorders, sleep bruxism, and primary headaches are mutually associated. (23424716)
2013
8
Alpha thalassaemia due to non-deletional mutations on the -3.7 alpha globin fusion gene: laboratory diagnosis and clinical importance. (24018802)
2013
9
Cysts and swellings: a systematic review of the association between polycystic kidney disease and abdominal aortic aneurysm. (23088808)
2013
10
Reference ranges for assessment of unilateral lymphedema in legs by bioelectrical impedance spectroscopy. (21417766)
2011
11
Esophageal tuberculosis mimicking submucosal leiomyoma- report of a case. (23204713)
2011
12
miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications. (21885871)
2011
13
Effect of treatment with cyproterone acetate on uterine bleeding at the beginning of GnRH analogue therapy in girls with idiopathic central precocious puberty. (20389110)
2010
14
Dietary virgin olive oil reduces blood brain barrier permeability, brain edema, and brain injury in rats subjected to ischemia-reperfusion. (20602077)
2010
15
Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH. (20102399)
2010
16
Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer. (20663721)
2010
17
Desmosomal plakophilins in the prostate and prostatic adenocarcinomas: implications for diagnosis and tumor progression. (20348237)
2010
18
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. (19329498)
2009
19
Metabolic syndrome and reproduction: I. testicular function. (18224542)
2008
20
Differential expression of ghrelin and its receptor (GHS-R1a) in various adrenal tumors and normal adrenal gland. (18246525)
2008
21
Holt-Oram syndrome in two generations with translocation t(9;15)(p12;q11.2). (18500176)
2008
22
Education and imaging. Hepatobiliary and pancreatic: choledochal cyst. (18031400)
2007
23
Transcriptional repression of matrix metalloproteinase gene expression by the orphan nuclear receptor NURR1 in cartilage. (17283078)
2007
24
Progressive extragenital lichen sclerosus successfully treated with narrowband UV-B phototherapy. (17224537)
2007
25
Rescue of vasopressin V2 receptor mutants by chemical chaperones: specificity and mechanism. (16267275)
2006
26
Prostaglandin D2 induces IL-8 and GM-CSF by bronchial epithelial cells in a CRTH2-independent pathway. (16940740)
2006
27
MMP-2 expression is associated with rapidly proliferative arteriosclerosis in the flexor tenosynovium and pain severity in carpal tunnel syndrome. (15685708)
2005
28
Skull base chordoma. (15641104)
2005
29
Phosphatidylserine externalization in human sperm induced by calcium ionophore A23187: relationship with apoptosis, membrane scrambling and the acrosome reaction. (16113043)
2005
30
Expression of serotonin receptors 2B and 4 in human prostate cancer tissue and effects of their antagonists on prostate cancer cell lines. (15925089)
2005
31
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. (15541308)
2004
32
Expression of nestin in ballooned neurons in patients with Creutzfeldt-Jakob disease. (15276235)
2004
33
Cerebrovascular response to repetitive visual stimulation in interictal migraine with aura. (15315525)
2004
34
Mirizzi syndrome: a diagnostic and operative challenge. (15570778)
2003
35
The inhibition of semicarbazide-sensitive amine oxidase by aminohexoses. (12686159)
2003
36
Tissue-specific impairment of insulin signaling in vasculature and skeletal muscle of fructose-fed rats. (12627878)
2003
37
Pulmonary involvement in a patient with dyskeratosis congenita. (14651554)
2003
38
Hedgehog-mediated patterning of the mammalian embryo requires transporter-like function of dispatched. (12372301)
2002
39
The attempt to identify mutations in TIGR gene in Polish patients with primary open angle glaucoma]. (10878948)
2000
40
Pharmacological characterization of antagonists of the C5a receptor. (10602324)
1999
41
Methyl methanesulfonate and hydrogen peroxide differentially regulate p53 accumulation in hepatoblastoma cells. (10403664)
1999
42
Liver urea and glucose production in patients with alcohol-induced cirrhosis]. (9072475)
1997
43
Multisite phosphorylation of ornithine decarboxylase in transformed macrophages results in increased intracellular enzyme stability and catalytic efficiency. (8798774)
1996
44
Molecular cloning of 25-hydroxyvitamin D-3 24-hydroxylase (Cyp-24) from mouse kidney: its inducibility by vitamin D-3. (7578252)
1995
45
Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-Jun. (7759501)
1995
46
Specific expression of insulin-like growth factor-II in rhabdomyosarcoma tumor cells. (8116575)
1994
47
Expression of c-kit and kit ligand in human colon carcinoma cells. (7694350)
1993
48
Role of transforming growth factor beta in the pathophysiology of chronic inflammation. (8315567)
1993
49
Nitrogen dioxide exposure and development of pulmonary emphysema. (3634023)
1986
50
Surgical treatment of gastrojejunal ulcer. (15428230)
1950

Variations for Blastic Plasmacytoid Dendritic Cell

About this section

Expression for genes affiliated with Blastic Plasmacytoid Dendritic Cell

About this section
Search GEO for disease gene expression data for Blastic Plasmacytoid Dendritic Cell.

Pathways for genes affiliated with Blastic Plasmacytoid Dendritic Cell

About this section

Pathways related to Blastic Plasmacytoid Dendritic Cell according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.6CD4, NCAM1, PECAM1
29.4CD4, IL3RA, NCAM1
38.1CD4, CLEC4C, IL3RA, NCAM1, SPIB

GO Terms for genes affiliated with Blastic Plasmacytoid Dendritic Cell

About this section

Biological processes related to Blastic Plasmacytoid Dendritic Cell according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1negative regulation of cyclin-dependent protein serine/threonine kinase activityGO:004573610.2CDKN1B, CDKN2A
2viral entry into host cellGO:004671810.1CD4, NCAM1
3negative regulation of phosphorylationGO:004232610.1CDKN1B, CDKN2A
4neurotrophin TRK receptor signaling pathwayGO:00480118.7CDKN1B, IL3RA, MYD88, NCAM1
5innate immune responseGO:00450878.6CD4, CDKN1B, IL3RA, MYD88, NCAM1

Sources for Blastic Plasmacytoid Dendritic Cell

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet